Amferia AB
↗Mölndal, Sweden
Amferia is a Swedish medtech company founded in 2018 as a spin-off from Chalmers University of Technology. The company specializes in developing innovative medical devices based on a proprietary antimicrobial peptide (AMP) hydrogel platform designed to combat antibiotic-resistant bacterial infections in both human and animal health.
The company's core technology utilizes peptides that physically puncture bacterial cell membranes, a mechanism that is effective against antibiotic-resistant strains without harming surrounding tissue. Amferia is actively commercializing its wound care solutions in the veterinary market through partnerships and is advancing its pipeline for human clinical applications, with a focus on regulatory approval in the US and Europe.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:-
Industry:Medical Devices
Sub-Industry:Wound Care / Antimicrobial Technology
SIZE & FINANCIALS
Employees:1-50
Founded:2018
Ownership:private
Status:operating
FUNDING
Stage:Series B
Total Raised:$8M+
Investors:Chalmers Ventures, Almi Invest VästSverige, Corinthian Property Management
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial (Veterinary Wound Dressing)
Modalities:Antimicrobial Peptides, Hydrogel
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Orkla Wound Care AB (Animal health distribution), Biokema SA (Animal health distribution in Switzerland), Magnum Veterinaaria (Animal health distribution in Baltics), Grovet BV (Animal health distribution in Benelux)
COMPETITION
Position:Emerging
Competitors:Cel-Sci, Aethlon Medical, Cerus
LEADERSHIP
Key Executives:
Anand Kumar Rajasekharan - CEO & Co-Founder
Saba Atefyekta - Marketing Director & Co-Founder
Martin Andersson - R&D Director & Co-Founder
Ingvar Karlsson - CFO
Scientific Founders:Anand Kumar Rajasekharan, Saba Atefyekta, Martin Andersson
Board Members:Agneta Edberg (Chairman)
LINKS
Website:amferia.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Amferia AB and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Amferia AB. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.